Bicara Therapeutics, Inc. (BCAX)
21.57
-0.41
(-1.87%)
USD |
NASDAQ |
May 27, 16:00
21.57
0.00 (0.00%)
After-Hours: 18:34
Bicara Therapeutics Free Cash Flow : -116.58M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Bridgebio Oncology Therapeutics, Inc. | -149.71M |
| Viridian Therapeutics, Inc. | -304.30M |
| ACADIA Pharmaceuticals, Inc. | 113.59M |
| Agenus, Inc. | -87.53M |
| Alnylam Pharmaceuticals, Inc. | 641.34M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -37.51M |
| Cash from Investing (Quarterly) | 100.94M |
| Cash from Financing (Quarterly) | 163.34M |
| Free Cash Flow Per Share (Quarterly) | -0.6187 |
| Free Cash Flow to Equity (Quarterly) | -37.30M |
| Free Cash Flow to Firm (Quarterly) | -37.57M |
| Free Cash Flow Yield | -9.61% |